Acromegaly Treatment Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION

Acromegaly is a hormonal disease caused due to excess production of growth hormone by pituitary gland in adults and affects the physical appearance and internal organs of patients. It is generally caused by benign pituitary tumor. Some of the symptoms of acromegaly are enlargement of feet and hands, also it may cause changes in shape of face. The acromegaly may lead to many health problems such as goiter, cardiovascular disorders, hypertension and others.

MARKET DYNAMICS

The acromegaly treatment market is expected to grow in coming years owing to factors such as rise in genetic disorders, increase in incidences of hormonal diseases such as hypopituitarism and endocrine diseases, advancement in technology and investment in R&D technique for drug development and others. On the other hand there are number of drug in pipeline for the treatment of acromegaly is likely offer opportunities for market growth.

MARKET SCOPE

The "Global Acromegaly Treatment Market Analysis to 2031" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of acromegaly treatment market with detailed market segmentation by disease, drug class, route of administration, distribution channel and geography. The global acromegaly treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading acromegaly treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global acromegaly treatment market is segmented on the basis of disease, drug class, route of administration and distribution channel. Based on disease, the market is segmented as ectopic acromegaly and pseudo acromegaly. Based on drug class the acromegaly treatment market is segmented as Somatostatin analogs (SSAS), Somatuline depot (lanreotide), others SSAs, dopamine agonists (DAs), bromocriptine mesylate, others DAs, growth hormone receptor antagonist (GHRAs) and somavert (Pegvisomant). On the basis of route of administration, the market is segmented into oral and parenteral On the basis of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global acromegaly treatment market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The acromegaly treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting acromegaly treatment market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the acromegaly treatment market in these regions.

MARKET PLAYERS

The reports cover key developments in the acromegaly treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from acromegaly treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for acromegaly treatment in the global market. Below mentioned is the list of few companies engaged in the acromegaly treatment market.

The report also includes the profiles of key acromegaly treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

• Novartis AG
• Pfizer Inc.
• Mylan N.V.
• Zydus Pharmaceuticals, Inc.
• Ipsen Pharma
• Validus Pharmaceuticals LLC
• Teva Pharmaceutical Industries Ltd.
• Sandoz International GmbH
• Fresenius Kabi
• Foresee Pharmaceuticals LLC

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Acromegaly Treatment Report Scope